Abbott is asking one million people worldwide. Here’s why and how.

Danica Patrick All Smiles as Aspen Dental Management, Inc. Extends Partnership, Doubles Commitment

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

West Pharmaceutical Services, Inc. And HealthPrize Technologies Announce Self-Reporting And Barcoding Capabilities For Self-Injection Technology

American Association for Cancer Research National Survey Shows 74 Percent of Voters Want More Federal Funding for Cancer Research

New Myths and Truths About Thyroid Cancer Education Initiative Aims to Shine a Light on the Truths about Thyroid Cancer

Cardinal Health Introduces Hospital Quality at Home™ Products

New 5-Year Results of a Landmark Study Confirm LINX Procedure as a Beneficial Treatment for Gastro-esophageal Reflux Disease

AbbVie’s HUMIRA® (Adalimumab) Receives First and Only U.S. Food and Drug Administration Approval for Moderate to Severe Hidradenitis Suppurativa

Urology Care Foundation and NFL Kick-Off Another Great Season for Prostate Cancer Awareness

BAYER PLEDGES 1 MILLION HANDS-ON SCIENCE LEARNING EXPERIENCES FOR CHILDREN BY 2020 TO HELP INSPIRE NEXT GENERATION OF INNOVATORS

Researchers and Advocates Recognized for Their Contributions in the Fight Against Cancer

Vitamin Bee Teams Up with Bayer Bee Care Program for Feed a Bee Initiative

Most Americans Don’t Know an Important Health Number that Could Be Putting Them at Risk for Gout

US FDA APPROVES EXPANDED INDICATION FOR BRILINTA TO INCLUDE LONG-TERM USE IN PATIENTS WITH A HISTORY OF HEART ATTACK

Humana Celebrates Health Benefits of National Parks

Brian Custer Teams Up with the Prostate Cancer Foundation to Urge Men to “Man Up and Get Checked”

Invest in a Child’s Future: St. Baldrick’s Foundation Calls for Increased Focus on Funding Pediatric Cancers

CeQur Announces $100 Million Series C Financing

WHAT WOMEN NEED TO KNOW ABOUT ATRIAL FIBRILLATION AND STROKE RISK

Duchesnay USA Publishes Corrective Messaging through Kim Kardashian’s Social Media Accounts in Response to FDA’s Request

PROOF OF IMPACT: THE LEUKEMIA & LYMPHOMA SOCIETY IS MAKING PROGRESS TOWARD A WORLD WITHOUT BLOOD CANCERS

FDA APPROVES AMGEN’S NEW CHOLESTEROL-LOWERING MEDICATION REPATHA™ (EVOLOCUMAB)

September is Childhood Cancer Awareness Month St. Jude Children's Research Hospital® encourages communities to join the fight

IT’S A TRAP: SOCIAL SMOKING IS SMOKING [truth®VIDEO]